Amneal Pharmaceuticals, Inc.
AMRXNasdaqCIK 1723128HealthcareFiscal year ends Dec 31
Reports and events: 191 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2022-05-0406:11 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001723128-22-000012 |
| 2022-03-2508:00 ET | DEF 14A | Proxy statementPeriod 2022-05-09 | 0001308179-22-000119 |
| 2022-03-1617:20 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-22-077358 |
| 2022-03-0206:12 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001723128-22-000008 |
| 2022-03-0116:45 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001723128-22-000006 |
| 2022-01-1917:32 ET | SC 13D/A | Ownership report, active investor, amended | 0001387131-22-000440 |
| 2022-01-1108:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure | 0001193125-22-006322 |
| 2022-01-0506:16 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-002140 |
| 2021-11-0816:43 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001723128-21-000039 |
| 2021-11-0306:17 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001723128-21-000035 |
| 2021-08-0916:05 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001723128-21-000032 |
| 2021-08-0906:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001723128-21-000028 |
| 2021-05-1016:24 ET | 8-K | 5.07 Shareholder vote results | 0001193125-21-156284 |
| 2021-05-0716:16 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001723128-21-000023 |
| 2021-05-0706:17 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001723128-21-000020 |
| 2021-04-0508:03 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-21-105627 |
| 2021-03-2408:00 ET | DEF 14A | Proxy statementPeriod 2021-05-05 | 0001308179-21-000093 |
| 2021-03-0116:10 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001723128-21-000013 |
| 2021-02-2606:35 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001723128-21-000008 |
| 2021-02-1616:14 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-21-044889 |
| 2021-01-1206:15 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-21-006720 |
| 2020-12-1816:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-20-321461 |
| 2020-11-0616:19 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001723128-20-000026 |
| 2020-11-0606:13 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001723128-20-000023 |
| 2020-08-0616:22 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0001723128-20-000013 |
| 2020-08-0606:09 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001723128-20-000010 |
| 2020-08-0416:16 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-20-209316 |
| 2020-05-1116:32 ET | 10-Q | Quarterly reportPeriod 2020-03-31 | 0001564590-20-024256 |
| 2020-05-1106:47 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-20-023833 |
| 2020-05-0807:43 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001193125-20-136972 |
| 2020-04-1716:05 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001193125-20-110622 |
| 2020-03-2316:31 ET | DEF 14A | Proxy statementPeriod 2020-05-05 | 0001308179-20-000070 |
| 2020-03-1217:19 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-20-071730 |
| 2020-03-0216:33 ET | 10-K | Annual reportPeriod 2019-12-31 | 0001564590-20-008179 |
| 2020-02-2616:55 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-20-050188 |
| 2020-02-2606:50 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-20-006564 |
| 2020-02-2016:49 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0001193125-20-043613 |
| 2020-02-2016:47 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0001193125-20-043609 |
| 2020-02-0419:51 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-20-023178 |
| 2020-01-1510:32 ET | 8-K | 7.01 Regulation FD disclosure | 0001193125-20-007787 |
| 2019-12-1616:50 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-19-315267 |
| 2019-12-1016:51 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-19-310283 |
| 2019-11-0720:09 ET | 10-Q | Quarterly reportPeriod 2019-09-30 | 0001564590-19-041240 |
| 2019-11-0606:54 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-19-040651 |
| 2019-10-1112:07 ET | 8-K | 5.07 Shareholder vote results | 0001193125-19-266540 |
| 2019-09-1117:14 ET | SC 13D/A | Ownership report, active investor, amended | 0000898432-19-001162 |
| 2019-08-2617:27 ET | SC 13D/A | Ownership report, active investor, amended | 0000898432-19-001109 |
| 2019-08-2617:27 ET | SC 13D/A | Ownership report, active investor, amended | 0000898432-19-001108 |
| 2019-08-0720:39 ET | SC 13D/A | Ownership report, active investor, amended | 0000914121-19-002138 |
| 2019-08-0720:37 ET | SC 13D/A | Ownership report, active investor, amended | 0000914121-19-002136 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 10, 2026, 02:45 ET. Listed shows no prices and gives no investment advice.